ATS 2018 International Conference - Mobile

Development and Efficacy of a Novel Nebulized Antibiotic Formulation for the Treatment of Mycobacterium Abscessus Pulmonary Infections

Location: PRE-FUNCTION 8-9

Session Type: Mini Symposium

Tuesday

May

22

3:45 PM

4:00 PM

Speaker(s)/Author(s)

Megan Stapleton

MSc
Microbiology, Immunology, Pathology

Stefan Ufer

MSc
QrumPharma, Inc

Diane Ordway

PhD
Microbiology, Immunology, Pathology

Deepshikha Verma

PhD
Microbiology, Immunology, Pathology

Marius Hittinger

MSc
PharmBioTec GmbH

Kevin Stapleton

PhD
QrumPharma, Inc

Brandon Banaschewski

PhD
QrumPharma, Inc

Thomas Hofmann

MD, PhD
QrumPharma, Inc

Claus-Michael Lehr

PhD
PharmBioTec GmbH

View Abstract

Development and Efficacy of a Novel Nebulized Antibiotic Formulation for the Treatment of Mycobacterium Abscessus Pulmonary Infections

Parent Sessions

C96 - ADVANCES IN THE MANAGEMENT OF PULMONARY NTM DISEASE...
05-22-2018 2:15 PM - 4:15 PM